2026 NPPES data Clinical Nurse Specialist NPI 1942346531 CNS
Verify on CMS →

MICHAEL LAFERNEY, CNS

Clinical Nurse Specialist in ROCKLAND, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 46 beneficiaries · Clinical Nurse Specialist avg: 953
Generic prescribing
98%
generic claims · 2% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
25.7926/100
▼ 57 pts below national avg 83.1 · [object Object]
What the federal data reveals: MICHAEL LAFERNEY, CNS is a Clinical Nurse Specialist ([object Object]) practicing in ROCKLAND, Massachusetts with a Medicare Part D prescribing footprint of 2K claims across 46 beneficiaries — 2% brand-name prescribing . Their CMS MIPS Final Score of 25.7926/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: MICHAEL LAFERNEY, CNS reported a CMS MIPS final score of 25.7926 out of 100, below the 83.1 national average, and filed 1,738 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

MICHAEL LAFERNEY, CNS at a glance

Below national average

NPI registry status

Active

Issued 01/30/2007

NPI 1942346531

Primary specialty

Clinical Nurse Specialist

Niche

1,708 US NPIs in this specialty

Medicare Part D claims

1,738 82% vs specialty avg

2023 prescription claims

Specialty avg: 953

MIPS final score

25.7926/100 57.307399999999994% pts

Below average band

vs 83.1 national avg

Specialty distribution in Massachusetts

How Clinical Nurse Specialist compares to other specialties among Massachusetts providers

Massachusetts providers

Clinical Nurse Specialist share within Massachusetts

1. Clinical Nurse Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Clinical Nurse Specialist share within Massachusetts

Medicare quality performance — MIPS

MICHAEL LAFERNEY, CNS's 2023 MIPS final score plotted against the Clinical Nurse Specialist national average

Below national average
MIPS Final Score
25.7926/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Clinical Nurse Specialist) — 25.7926/100 vs national avg 83.1

0%100%National avg83%25.8%
MIPS final score (Clinical Nurse Specialist) — 25.7926/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHAEL LAFERNEY, CNS is a Clinical Nurse Specialist provider practicing in ROCKLAND, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: CNS. NPI: 1942346531. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MICHAEL LAFERNEY, CNS appears in the CMS NPPES registry as a Clinical Nurse Specialist provider holding CNS credentials at 100 LEDGEWOOD PL, ROCKLAND, MA, 02370, with a listed phone of (781) 871-6550. NPI 1942346531 was issued on 01/30/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LAFERNEY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,738 prescription claims written by this provider, covering 46 Medicare beneficiaries and totaling roughly $112K in drug spend, split 2% brand-name and 98% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 25.7926/100 for the 2023 performance year (Quality 0, Cost 85.9752), compared with the national average of 83.1.

Clinical Nurse Specialist is a narrow specialty nationwide, with 1,708 enrolled providers across 49 states and an average of 953 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

100 LEDGEWOOD PL
ROCKLAND, MA 02370

Provider Details

NPI 1942346531
Specialty Clinical Nurse Specialist
Credentials CNS
Gender Male
NPI Issued 01/30/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

25.7926
Final Score
Avg: 83.1
0
Quality
85.9752
Cost
0
Promoting Interoperability

Reporting: Individual

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to MICHAEL LAFERNEY, CNS. To verify MICHAEL LAFERNEY, CNS's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MICHAEL LAFERNEY, CNS — brand share 2.0%
Specialty average (est.)

2% brand-name claims vs 98% generic, on 1,738 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,738
Total Claims
$112K
Total Drug Cost
46
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,738
Total Day Supply
50,429
Brand vs Generic
2% brand / 98% generic
Brand Drug Cost
$59K
Generic Drug Cost
$53K

Patient Demographics

Average Patient Age
63.7 years
Avg HCC Risk Score
2.05
Gender Split
48% female / 52% male
Age Distribution
<65: 18, 65-74: 27, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Gabapentin
116
Quetiapine Fumarate
106
Trazodone Hcl
102
Clonazepam
95
Clozapine
89
Risperidone
82
Benztropine Mesylate
77
Lorazepam
66
Olanzapine
66
Duloxetine Hcl
65

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Clinical Nurse Specialist Overview

How MICHAEL LAFERNEY, CNS fits within the Clinical Nurse Specialist landscape nationally.

1,708
Clinical Nurse Specialist Providers in US
49
States with Clinical Nurse Specialist
953
Avg Claims per Provider

MICHAEL LAFERNEY, CNS's 1,738 claims are above the specialty average of 953.

Nearby Clinical Nurse Specialist Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as LAFERNEY.

Compare Clinical Nurse Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHAEL LAFERNEY, CNS's specialty?
MICHAEL LAFERNEY, CNS specializes in Clinical Nurse Specialist and practices in ROCKLAND, Massachusetts. Credentials: CNS.
How much does MICHAEL LAFERNEY, CNS prescribe under Medicare Part D?
In 2023, MICHAEL LAFERNEY, CNS wrote 1,738 Medicare Part D claims totaling $112K in drug costs for 46 beneficiaries.
What is MICHAEL LAFERNEY, CNS's Medicare quality score?
MICHAEL LAFERNEY, CNS has a CMS MIPS Final Score of 25.7926/100 (Quality: 0, Cost: 85.9752). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MICHAEL LAFERNEY, CNS located?
MICHAEL LAFERNEY, CNS is located at 100 LEDGEWOOD PL, ROCKLAND, MA, 02370. Phone: (781) 871-6550.
What is MICHAEL LAFERNEY, CNS's NPI number?
MICHAEL LAFERNEY, CNS's National Provider Identifier (NPI) is 1942346531, issued on 01/30/2007.
Does MICHAEL LAFERNEY, CNS prescribe more brand-name or generic drugs?
MICHAEL LAFERNEY, CNS's prescribing is 2% brand-name and 98% generic drugs by claim count, with $59K in brand drug costs.
How many Clinical Nurse Specialist providers are there in the US?
There are 1,708 Clinical Nurse Specialist providers across 49 states in the US. The average Clinical Nurse Specialist provider writes 953 Medicare Part D claims per year.
What drugs does MICHAEL LAFERNEY, CNS prescribe most often?
Based on 2023 Medicare Part D data, MICHAEL LAFERNEY, CNS's most frequently prescribed drugs include Gabapentin, Quetiapine Fumarate, Trazodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHAEL LAFERNEY, CNS accept Medicare?
MICHAEL LAFERNEY, CNS appears in CMS Medicare data with 1,738 Part D claims and 46 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHAEL LAFERNEY, CNS's credentials?
MICHAEL LAFERNEY, CNS's NPI is 1942346531 with credentials CNS. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology